Company Overview and News

3
Veritas Pharma Signs R&D and Medical Cannabis Supply Agreement with Colombian Producer Foliumed S.A.S.

2018-06-18 globenewswire
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP), (“Veritas” or the “Company”) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with Colombian medical cannabis company Foliumed S.A.S. (“Foliumed”).
VRT VRTHF

3
Greenstream Announces Appointment of Business Development and Strategy Professional, Justin Kausel

2018-06-04 globenewswire
VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) -- BLOK Technologies Inc. ("BLOK Tech" or the "Company") (CSE:BLK) (FRANKFURT:2AD) is pleased to announce that Justin Kausel has joined the Company as Director of Business Development for BLOK Tech’s 100% wholly-owned subsidiary Greenstream Networks Inc. (“Greenstream”). Justin will be responsible for the Company’s business development strategy and implementation of new business opportunities in the cannabis sector for Greenstream.
VRT VRTHF

3
Veritas Pharma Provides Corporate Update on Q2 2018

2018-05-31 globenewswire
VANCOUVER, British Columbia, May 31, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to provide a corporate update on its achievements, related scientific activities and growth strategies for the second quarter of fiscal 2018.
VRT VRTHF

3
Veritas Pharma Has Retained Cannabis Branding Firm for Design of Label and Packaging

2018-05-15 globenewswire
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce with the dealer licence being granted which was previously announced on December 28, 2017, the Company has now engaged a branding firm in the development of label and package design in compliance of Health Canada regulations. Veritas is applying to amend Cannevert’s Dealer Licence such that the Company can package Cannevert products including CTL-X for sale to licensed producers in Canada and for the export market.
VRT VRTHF

3
Veritas Pharma Provides Comment on Canadian Senate Recommendation for a One-Year Deferment Legalizing Cannabis

2018-05-10 globenewswire
VANCOUVER, British Columbia, May 10, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) provides the following statement to the recommendation issued by Members of the Standing Senate Committee on Aboriginal Peoples calling for a one-year deferment to allow for further consultation with Indigenous groups on May 1, 2018.
VRT VRTHF

3
Veritas Pharma Establishes New Subsidiary in Puerto Rico, USA

2018-05-07 globenewswire
VANCOUVER, British Columbia, May 07, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce the establishment of new subsidiary Veritas Pharma Puerto Rico LLC (“Veritas PR”) in the US territory. With the management and regulatory guidance of Essèntium Group LLC, Veritas PR establishes a foothold for the scientific investigation, product development and commercialization of cannabis-based therapies in Puerto Rico and throughout Latin America.
VRT VRTHF

17
Dr. Michael K. Pugsley Joins Veritas Pharma’s Advisory Board

2018-04-18 globenewswire
VANCOUVER, British Columbia, April 18, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Michael K. Pugsley PhD, FBPhS, DSP, a consultant in safety pharmacology, has joined its advisory board. Dr. Pugsley is a safety pharmacologist and toxicologist specialized in a variety of therapeutic areas in drug development, in particular, central nervous system, anti-inflammatory, oncology, myocardial infarction, and congestive heart failure.
VRT VRTHF ABCO

3
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.

2018-04-16 globenewswire
VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into a Share Purchase Agreement (“Purchase Agreement”) with 3 Carbon Extractions Inc. (“3 Carbon”) to acquire Fifty Percent (50%) of the issued and outstanding shares of 3 Carbon.
VRT VRTHF

20
Stamper Oil & Gas Provides Corporate Update

2018-04-11 globenewswire
VANCOUVER, British Columbia, April 11, 2018 (GLOBE NEWSWIRE) -- Stamper Oil & Gas Corp. (TSX-V:STMP) (FSE:TMP2) (OTCQB:STMGF) (“Stamper” or “the Company”), is pleased to provide an update to its current and prospective Stamper Shareholders regarding the Company for the first three months of 2018.
VRT MDM VRTHF ABCO MRPHF

10
Stamper Oil & Gas Announces the Appointment of David M. Alexander CPA, CA as CFO

2018-03-27 globenewswire
VANCOUVER, British Columbia, March 27, 2018 (GLOBE NEWSWIRE) -- Stamper Oil & Gas Corp. (TSX-V:STMP) (FSE:TMP2) (OTCQB:STMGF) (“Stamper” or “the Company”) today is pleased announce the appointment of David M. Alexander, CPA, CA as Chief Financial Officer of the Company, to take effect on April 1st, 2018. Mr. Alexander replaces Mr. Omair Choudhry as CFO. Stamper thanks Mr. Choudhry for his services and dedication while in the role of CFO of the Company.
VRT MDM VRTHF COM MRPHF CRME

8
Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics

2018-03-21 globenewswire
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP) (“Veritas” or the “Company”) is pleased to announce the Company has completed the 100% takeover of its research arm, Cannevert Therapeutics Ltd. (“CTL”).
VRNA VRP VNAPF VRT VRTHF COM CRME

Related Articles

HIMX: Himax Technologies Analysis and Research Report

19h - Asif

History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

Silicon Investor Message Boards

This table lists all message boards related to CNSX:VRT / Seashore Organic Marijuana Corp on message board site Silicon Investor.

Vertex Pharmaceuticals (VRTX) VRTC: VERITEC INC.
Veritas (VRTS) Vertel (VRTL) 10xbagger in the making
Verity (VRTY) VRTX: Vertex Pharmaceuticals
VRTL: Vertel Corp. Virata Corporation (VRTA)
Techs, ANLY, PSCX,, TDS, VRTS, Articles BVR Technologies (NASDAQ:BVRT)Netgames